- Report
- August 2025
- 150 Pages
Global
From €2537EUR$2,850USD£2,192GBP
€3427EUR$3,850USD£2,961GBP
- Report
- March 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- August 2025
- 487 Pages
Global
From €5207EUR$5,850USD£4,499GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1335EUR$1,500USD£1,154GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1780EUR$2,000USD£1,538GBP
- Report
- July 2025
- 350 Pages
Global
From €4405EUR$4,949USD£3,806GBP
- Report
- June 2025
- 400 Pages
Global
From €4405EUR$4,949USD£3,806GBP
- Report
- April 2025
- 192 Pages
Global
From €4446EUR$4,995USD£3,841GBP
- Report
- July 2025
- 120 Pages
Global
From €5296EUR$5,950USD£4,576GBP
- Report
- August 2025
- 563 Pages
Global
From €5207EUR$5,850USD£4,499GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2483EUR$2,789USD£2,145GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2483EUR$2,789USD£2,145GBP
- Report
- July 2025
- 175 Pages
Global
From €3997EUR$4,490USD£3,453GBP
- Report
- July 2024
- 150 Pages
Global
From €5296EUR$5,950USD£4,576GBP
- Report
- May 2023
- 260 Pages
Global
From €2359EUR$2,650USD£2,038GBP
- Report
- June 2024
- 200 Pages
Global
From €7077EUR$7,950USD£6,114GBP
- Report
- June 2024
- 200 Pages
Global
From €7077EUR$7,950USD£6,114GBP
- Report
- January 2022
- 60 Pages
Global
From €3516EUR$3,950USD£3,038GBP
- Report
- January 2022
- 60 Pages
Global
From €3516EUR$3,950USD£3,038GBP
- Report
- May 2024
- 137 Pages
Global
From €5785EUR$6,499USD£4,998GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more